Mesenchymal stem cell–derived exosome delivery of let-7a-5p enhances macrophage efferocytosis via Arid3a/Mertk axis in acute-on-chronic liver failure
Stem Cells Translational Medicine · 24.11.2025 · 14 (12)
DOI: 10.1093/stcltm/szaf058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 02.12.2025. Verfasst von Junyi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. Hauptthemen laut MEDLINE: Exosomes, MicroRNAs, c-Mer Tyrosine Kinase, Acute-On-Chronic Liver Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Acute-on-chronic liver failure (ACLF) is a severe clinical syndrome with a high mortality rate and limited therapeutic options. Macrophage efferocytosis plays an essential role in maintaining tissue homeostasis, and its dysfunction may be associated with the pathogenesis of ACLF. We previously found that mesenchymal stem cell (MSC) treatment in ACLF mice promoted macrophage M2 polarization and elevated the efferocytosis-related protein Mertk, but the underlying mechanisms remained unclear.
Methods
The role of efferocytosis was investigated in liver tissues from ACLF patients and an ACLF mouse model treated with MSC-derived exosomes (MSC-Exos). In vitro experiments utilizing lipopolysaccharide-induced M1 macrophages were conducted to dissect the underlying mechanism, targeting the miRNA let-7a-5p. Engineered exosomes (MSC-Exoslet-7a-5p) were developed via electroporation to validate the therapeutic potential.
Results
Impaired macrophage efferocytosis in liver tissues correlated with poor prognosis in ACLF patients. Treatment with MSC-Exos significantly improved histological morphology, liver function and enhanced efferocytosis in ACLF mice. Mechanistically, MSC-Exos delivered let-7a-5p to M1 macrophages, which downregulated Arid3a and upregulated Mertk expression. Furthermore, engineered MSC-Exoslet-7a-5p promoted efferocytosis more effectively than unmodified exosomes.
Conclusion
MSC-Exos enhance macrophage efferocytosis in ACLF via the let-7a-5p/Arid3a/Mertk axis. Engineered MSC-Exoslet-7a-5p, by boosting this pathway, provide a potential strategy for improving ACLF therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
- Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
- Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, China.
ORCID-Profile: Junyi Wang, Zhihui Li, Junfeng Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Li, Z., Wang, Z., Liang, W., Meng, S., Chen, J., Wang, J., Zhang, J., & Lin, B. (2025). Mesenchymal stem cell–derived exosome delivery of let-7a-5p enhances macrophage efferocytosis via Arid3a/Mertk axis in acute-on-chronic liver failure. Stem Cells Translational Medicine, 14(12). https://doi.org/10.1093/stcltm/szaf058
Vancouver
Wang J, Li Z, Wang Z, Liang W, Meng S, Chen J, et al. Mesenchymal stem cell–derived exosome delivery of let-7a-5p enhances macrophage efferocytosis via Arid3a/Mertk axis in acute-on-chronic liver failure. Stem Cells Translational Medicine. 2025;14(12). doi:10.1093/stcltm/szaf058
BibTeX
@article{Wang2025,
author = {Wang, Junyi and Li, Zhihui and Wang, Zhouhan and Liang, Wei and Meng, Shibo and Chen, Junfeng and Wang, Jialei and Zhang, Jing and Lin, Bingliang},
title = {Mesenchymal stem cell–derived exosome delivery of let-7a-5p enhances macrophage efferocytosis via Arid3a/Mertk axis in acute-on-chronic liver failure},
journal = {Stem Cells Translational Medicine},
year = {2025},
volume = {14},
number = {12},
doi = {10.1093/stcltm/szaf058}
}
EUVIMED